Bioinsecticide discovery platform for small hive beetle control

Overview

This research program addresses the growing threat posed by the small hive beetle (SHB, Aethina tumida), an invasive pest from South Africa that has spread across Australia's east coast. The beetle infests hives, consumes larvae and honey, and contaminates colonies with waste, ultimately driving bees to abscond when beetle populations reach critical thresholds.

The core challenge is that any treatment applied inside a hive inevitably affects the honeybee colony. This project overcomes that problem by computationally screening natural compounds for selective toxicity, identifying candidates that target the beetle's nervous system while sparing bees and mammals. The result is a pipeline of candidate bioinsecticides derived from natural sources, offering beekeepers effective pest management without harming pollinators.

Technical specifications

Target identification and screening approach:

• The beetle's glutamate-gated chloride channel (GluCl) was selected as the insecticide target site, a receptor critical to invertebrate nervous system function
• A library of 500 natural components was screened through molecular docking studies against the GluCl channel of Aethina tumida
• Molecular dynamics simulations validated the most promising receptor-ligand complexes based on binding affinity
• Compounds were prioritized for high-affinity binding to the beetle receptor while showing low-affinity binding to honeybee targets
• The screening identified small, naturally derived molecules with strong selectivity profiles

Validation pipeline:

• In silico screening and molecular dynamics simulations have been completed
• Planned bioassay testing will determine lethal dose thresholds against Aethina tumida and assess safety profiles for honeybees
• Formulation development (Beetlecide) will translate validated candidates into a deployable treatment suitable for hive application

Technology readiness level

The project is currently at an early-to-mid stage of development. The computational discovery phase, including target identification, molecular docking of 500 natural compounds, and molecular dynamics simulations, has been completed. Candidate compounds with favorable selectivity profiles have been identified.

The next stages involve experimental bioassays to confirm in vitro and in vivo efficacy and safety, followed by formulation work to develop a practical hive-applicable product. The research team is seeking collaboration to advance candidates through laboratory validation and formulation development toward field-ready bioinsecticide solutions.